Actively Recruiting
Low-Thermal Argon Plasma Devitalization Compared to Active Surveillance for Treating Cervical Intraepithelial Neoplasia Grade 2
Led by University Hospital Tuebingen · Updated on 2026-10-01
264
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of low-thermal argon plasma devitalization LtAPD compared to a sham procedure and active surveillance for treating Cervical Intraepithelial Neoplasia Grade 2 CIN 2. The studys goal is to determine if LtAPD leads to complete healing of this cervical tissue abnormality after six months, confirmed by microscopic examination of tissue samples. Participants are randomly assigned to receive either a single session of LtAPD treatment applied directly to the CIN 2 lesion without anesthesia or a sham treatment simulating the procedure without delivering plasma. Both groups continue with standard care involving active surveillance and regular monitoring during the six-month study, which includes four visits. Participants remain unaware of their assigned treatment. Throughout the study, participants undergo evaluations including tissue examinations, HPV remission assessment, cytological checks, and quality of life questionnaires at baseline, during intervention, and at six months. Researchers also analyze correlations between electrosurgical and video data with treatment outcomes. Safety and comfort are monitored, and the total participation lasts six months.
CONDITIONS
Brief Title
Evaluation of Low-thermal Argon Plasma Devitalization for the Treatment of CIN 2 Versus Standard of Active Surveillance
Research Team
M
Martin Weiss, Prof. Dr.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here